The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Targaxan 550 mg film-coated tablets



Norgine B.V.PA1336/009/001

Main Information

Trade NameTargaxan 550 mg film-coated tablets
Active SubstancesRifaximin
Dosage FormFilm-coated tablet
Licence HolderNorgine B.V.
Licence NumberPA1336/009/001

Group Information

ATC CodeA07AA Antibiotics
A07AA11 rifaximin

Status

License statusAuthorised
Licence Issued22/02/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back